Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

Three cohort studies in adults were performed during the period from 1986 to 1989. Eight hundred and eighty-four subjects were, one or more times, immunized with influenza vaccines, and pre- and post-vaccination antibody titres were determined by hemagglutination inhibition tests. One thousand and one hundred and nineteen vaccination events in 681 subjects could be analysed by a comparison, per trial and per influenza (sub)type, between groups with and without influenza vaccination in previous years. Effect size, odds ratio and protection rate difference, were used as effect measures. Subjects with previous vaccination showed higher pre-vaccination antibody than those without. The average change of the post-vaccination proportion of subjects with high antibody titre value to previous vaccination, was +9.4% (95% CI: +5.3 to 13.6%) for A-H3N2 vaccine components, -2.1% (-8.1 to 3.9%, not significant) for A-H1N1 and -10.6% (-16.5% to -4.8%) for B. In a linear regression model, pre-vaccination titres and the status of previous vaccination were identified as factors significantly influencing post-vaccination titres. These findings are discussed in the context of a short review of the literature. It is concluded that the status of previous vaccination should always be addressed as an independent factor in serological vaccination studies.

[1]  R. Douglas,et al.  Relation of chronic disease and immune response to influenza vaccine in the elderly. , 1989, Vaccine.

[2]  J. Davies,et al.  Natural or vaccine-induced antibody as a predictor of immunity in the face of natural challenge with influenza viruses , 1989, Epidemiology and Infection.

[3]  G L Ada,et al.  Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996). , 1997, Vaccine.

[4]  B. L. Beattie,et al.  Antibody response to whole-virus and split-virus influenza vaccines in successful ageing. , 1993, Vaccine.

[5]  R B Couch,et al.  Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. , 1988, American journal of epidemiology.

[6]  G. Dinant,et al.  Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial. , 1994, Vaccine.

[7]  K. Kerrebijn,et al.  Field trial with human and equine influenza vaccines in children: protection and antibody titres. , 1972, Bulletin of the World Health Organization.

[8]  R. Pyhälä,et al.  HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992. , 1994, Vaccine.

[9]  T. Hoskins,et al.  Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. , 1973, Lancet.

[10]  D. Jahnigen,et al.  Antibody Response of an Elderly Population to a Supplemental Dose of Influenza B Vaccine , 1988, Journal of the American Geriatrics Society.

[11]  J. Skehel,et al.  Antigenic similarity of influenza A (H1N1) viruses from epidemics in 1977--1978 to "Scandinavian" strains isolated in epidemics of 1950--1951. , 1978, Virology.

[12]  Christine Miller,et al.  INFLUENZA AT CHRIST'S HOSPITAL: MARCH, 1974 , 1976, The Lancet.

[13]  W. Beyer,et al.  Antibody induction by influenza vaccines in the elderly: a review of the literature. , 1989, Vaccine.

[14]  A. Steinschneider,et al.  Comparative responses of elderly persons to aqueous and depot influenza vaccines. , 1966, Archives of environmental health.

[15]  E. Lennette,et al.  Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections , 1989 .

[16]  FRCP W. J. MacLennan MD,et al.  The Elderly , 1984, Treatment in Clinical Medicine.

[17]  A. Grosche,et al.  Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people. , 1993, Vaccine.

[18]  N. Breslow,et al.  The analysis of case-control studies , 1980 .

[19]  E. Remarque,et al.  Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. , 1993, Vaccine.

[20]  Christine Miller,et al.  ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITAL , 1979, The Lancet.

[21]  N. Masurel,et al.  Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus , 1981, Journal of Hygiene.

[22]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[23]  B. Dawson-Saunders,et al.  Basic and Clinical Biostatistics , 1993 .

[24]  F. M. Davenport,et al.  A METHOD FOR INCREASING THE SENSITIVITY OF THE HEMAGGLUTINATION-INHIBITION TEST WITH EQUINE INFLUENZA VIRUS. , 1963, Virology.

[25]  W. Weimar,et al.  Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis. , 1990, Nephron.

[26]  F. Hayden,et al.  Immune response of adults to sequential influenza vaccination , 1984, Journal of medical virology.